BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28759216)

  • 1. Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.
    Acker TM; Gable JE; Bohn MF; Jaishankar P; Thompson MC; Fraser JS; Renslo AR; Craik CS
    J Am Chem Soc; 2017 Aug; 139(34):11650-11653. PubMed ID: 28759216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease dimer formation disrupted.
    Chmielewski J
    Nat Chem Biol; 2009 Sep; 5(9):607-8. PubMed ID: 19690531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a viral enzyme by a small-molecule dimer disruptor.
    Shahian T; Lee GM; Lazic A; Arnold LA; Velusamy P; Roels CM; Guy RK; Craik CS
    Nat Chem Biol; 2009 Sep; 5(9):640-6. PubMed ID: 19633659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus protease inhibition by dimer disruption.
    Shimba N; Nomura AM; Marnett AB; Craik CS
    J Virol; 2004 Jun; 78(12):6657-65. PubMed ID: 15163756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum allosteric inhibition of herpesvirus proteases.
    Gable JE; Lee GM; Jaishankar P; Hearn BR; Waddling CA; Renslo AR; Craik CS
    Biochemistry; 2014 Jul; 53(28):4648-60. PubMed ID: 24977643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme inhibition by allosteric capture of an inactive conformation.
    Lee GM; Shahian T; Baharuddin A; Gable JE; Craik CS
    J Mol Biol; 2011 Sep; 411(5):999-1016. PubMed ID: 21723875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.
    Gable JE; Lee GM; Acker TM; Hulce KR; Gonzalez ER; Schweigler P; Melkko S; Farady CJ; Craik CS
    ChemMedChem; 2016 Apr; 11(8):862-9. PubMed ID: 26822284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate modulation of enzyme activity in the herpesvirus protease family.
    Lazic A; Goetz DH; Nomura AM; Marnett AB; Craik CS
    J Mol Biol; 2007 Nov; 373(4):913-23. PubMed ID: 17870089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.
    Craik CS; Shahian T
    Methods Mol Biol; 2012; 928():119-31. PubMed ID: 22956137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.
    Reiling KK; Pray TR; Craik CS; Stroud RM
    Biochemistry; 2000 Oct; 39(42):12796-803. PubMed ID: 11041844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dimerization and ligand binding on the dynamics of Kaposi's sarcoma-associated herpesvirus protease.
    Bern D; Tobi D
    Proteins; 2022 Jun; 90(6):1267-1277. PubMed ID: 35084062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational change coupling the dimerization and activation of KSHV protease.
    Pray TR; Reiling KK; Demirjian BG; Craik CS
    Biochemistry; 2002 Feb; 41(5):1474-82. PubMed ID: 11814340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of proteases.
    Hauske P; Ottmann C; Meltzer M; Ehrmann M; Kaiser M
    Chembiochem; 2008 Dec; 9(18):2920-8. PubMed ID: 19021141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimerization-Induced Allosteric Changes of the Oxyanion-Hole Loop Activate the Pseudorabies Virus Assemblin pUL26N, a Herpesvirus Serine Protease.
    Zühlsdorf M; Werten S; Klupp BG; Palm GJ; Mettenleiter TC; Hinrichs W
    PLoS Pathog; 2015 Jul; 11(7):e1005045. PubMed ID: 26161660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational study on the inhibitor binding mode and allosteric regulation mechanism in hepatitis C virus NS3/4A protein.
    Xue W; Yang Y; Wang X; Liu H; Yao X
    PLoS One; 2014; 9(2):e87077. PubMed ID: 24586263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
    Unal A; Pray TR; Lagunoff M; Pennington MW; Ganem D; Craik CS
    J Virol; 1997 Sep; 71(9):7030-8. PubMed ID: 9261433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease.
    Pray TR; Nomura AM; Pennington MW; Craik CS
    J Mol Biol; 1999 Jun; 289(2):197-203. PubMed ID: 10366498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.
    Burrer CM; Foight GW; Keating AE; Chan GC
    Virus Res; 2016 Jan; 211():86-8. PubMed ID: 26456186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer.
    Maun HR; Liu PS; Franke Y; Eigenbrot C; Forrest WF; Schwartz LB; Lazarus RA
    J Biol Chem; 2018 Jun; 293(25):9614-9628. PubMed ID: 29661938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease.
    Greensill J; Sheldon JA; Murthy KK; Bessonette JS; Beer BE; Schulz TF
    AIDS; 2000 Dec; 14(17):F129-35. PubMed ID: 11125908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.